AnaptysBio (MEX:ANAB) Cyclically Adjusted FCF per Share: MXN-28.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ANAB AnaptysBio Inc MEX:ANAB
66 GF Score
Price MXN445.25
GF Value MXN427.80
! 5 Warning Signs
View Full Analysis

What is AnaptysBio Cyclically Adjusted FCF per Share?

AnaptysBio MEX:ANAB 66 Cyclically Adjusted FCF per Share is MXN-28.42 as of Mar. 2026. GuruFocus rates MEX:ANAB with a GF Score™ of 66/100 and a GF Value™ of MXN427.80. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

AnaptysBio's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-16.301. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-28.42 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-15), AnaptysBio's current stock price is MXN445.25081. AnaptysBio's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN-28.42. AnaptysBio's Cyclically Adjusted Price-to-FCF of today is .


AnaptysBio  (MEX:ANAB) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


AnaptysBio Cyclically Adjusted FCF per Share Related Terms


AnaptysBio Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for AnaptysBio's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnaptysBio Cyclically Adjusted FCF per Share Chart

AnaptysBio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -101.63 -31.00

AnaptysBio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -74.25 -66.36 -49.82 -31.00 -28.42

MEX:ANAB vs ABSI, TSHA, RXRX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, AnaptysBio's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AnaptysBio Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnaptysBio's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AnaptysBio's Cyclically Adjusted Price-to-FCF falls into.


MEX:ANAB
66GF Score
AnaptysBio Inc MEX:ANAB
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnaptysBio Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AnaptysBio's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-16.301/330.2130*330.2130
=-16.301

Current CPI (Mar. 2026) = 330.2130.

AnaptysBio Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 2.042 241.018 2.798
201609 -3.964 241.428 -5.422
201612 -6.325 241.432 -8.651
201703 -10.072 243.801 -13.642
201706 -2.417 244.955 -3.258
201709 -3.473 246.819 -4.646
201712 -4.190 246.524 -5.612
201803 -9.702 249.554 -12.838
201806 -7.539 251.989 -9.879
201809 -11.760 252.439 -15.383
201812 -9.152 251.233 -12.029
201903 -11.704 254.202 -15.204
201906 -11.200 256.143 -14.439
201909 -16.326 256.759 -20.997
201912 -11.043 256.974 -14.190
202003 -13.072 258.115 -16.723
202006 -16.663 257.797 -21.344
202009 -13.830 260.280 -17.546
202012 27.105 260.474 34.362
202103 -17.572 264.877 -21.906
202106 6.343 271.696 7.709
202109 -5.380 274.310 -6.476
202112 -18.861 278.802 -22.339
202203 -15.137 287.504 -17.386
202206 -17.280 296.311 -19.257
202209 -12.655 296.808 -14.079
202212 -7.443 296.797 -8.281
202303 -15.955 301.836 -17.455
202306 -16.481 305.109 -17.837
202309 -24.040 307.789 -25.791
202312 -22.113 306.746 -23.805
202403 -23.085 312.332 -24.407
202406 -14.301 314.175 -15.031
202409 -6.900 315.301 -7.226
202412 -45.824 315.605 -47.945
202503 -7.167 319.799 -7.400
202506 -26.328 322.561 -26.953
202509 -17.301 324.800 -17.589
202512 63.523 324.054 64.730
202603 -16.301 330.213 -16.301

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-28.42 mean?
AnaptysBio (MEX:ANAB) has a Cyclically Adjusted FCF per Share of MXN-28.42 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AnaptysBio and its competitors.
Is AnaptysBio's Cyclically Adjusted FCF per Share too high?
AnaptysBio's current Cyclically Adjusted FCF per Share is MXN-28.42. Overall, AnaptysBio has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does AnaptysBio's Cyclically Adjusted FCF per Share compare to ABSI and TSHA?
AnaptysBio's Cyclically Adjusted FCF per Share of MXN-28.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AnaptysBio and its competitors. AnaptysBio's current Cyclically Adjusted FCF per Share is MXN-28.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AnaptysBio stock overvalued right now?
AnaptysBio (MEX:ANAB) has a current Cyclically Adjusted FCF per Share of MXN-28.42. The stock's GF Value™ is MXN427.80, compared to a current price of MXN445.25 — trading 4.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN-28.42. AnaptysBio's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For AnaptysBio (MEX:ANAB), the current Cyclically Adjusted FCF per Share is MXN-28.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AnaptysBio (MEX:ANAB) Overvalued in 2026?

Based on GuruFocus' analysis, AnaptysBio stock appears to be overvalued. The current stock price of MXN445.25 is trading 4.1% above its estimated GF Value™ of MXN427.80.

Key valuation signals for MEX:ANAB:

  • Cyclically Adjusted FCF per Share: MXN-28.42
  • GF Value™: MXN427.80 vs. price of MXN445.25 (4.1% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the MEX:ANAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AnaptysBio Business Description

Other Exchanges ANAB:USA0HFQ:UKAN6:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
66GF Score

Get the complete analysis for MEX:ANAB

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN445.25
Price
MXN427.80
GF Value